[HTML][HTML] Micronutrients in HIV: a Bayesian meta-analysis
Background Approximately 28.5 million people living with HIV are eligible for treatment
(CD4< 500), but currently have no access to antiretroviral therapy. Reduced serum level of …
(CD4< 500), but currently have no access to antiretroviral therapy. Reduced serum level of …
[PDF][PDF] Micronutrients in HIV: A Bayesian Meta-Analysis
GM Carter, D Indyk, M Johnson, M Andreae… - PLoS …, 2015 - pdfs.semanticscholar.org
Background Approximately 28.5 million people living with HIV are eligible for treatment
(CD4< 500), but currently have no access to antiretroviral therapy. Reduced serum level of …
(CD4< 500), but currently have no access to antiretroviral therapy. Reduced serum level of …
Micronutrients in HIV: A bayesian meta-analysis
GM Carter, D Indyk, M Johnson, M Andreae… - PloS …, 2015 - einstein.elsevierpure.com
Background Approximately 28.5 million people living with HIV are eligible for treatment
(CD4< 500), but currently have no access to antiretroviral therapy. Reduced serum level of …
(CD4< 500), but currently have no access to antiretroviral therapy. Reduced serum level of …
Micronutrients in HIV: a Bayesian meta-analysis
GM Carter, D Indyk, M Johnson, M Andreae… - PloS …, 2015 - pubmed.ncbi.nlm.nih.gov
Background Approximately 28.5 million people living with HIV are eligible for treatment
(CD4< 500), but currently have no access to antiretroviral therapy. Reduced serum level of …
(CD4< 500), but currently have no access to antiretroviral therapy. Reduced serum level of …
[引用][C] Micronutrients in HIV: A Bayesian Meta-Analysis
GM Carter, D Indyk, M Johnson, M Andreae, K Suslov… - PLOS ONE, 2015 - cir.nii.ac.jp
Micronutrients in HIV: A Bayesian Meta-Analysis | CiNii Research CiNii 国立情報学研究所 学術
情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データをさがす 大学図書館の本を …
情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データをさがす 大学図書館の本を …
[引用][C] Micronutrients in HIV: A Bayesian Meta-Analysis
GM Carter, D Indyk, M Johnson, M Andreae… - PLOS …, 2015 - econpapers.repec.org
EconPapers: Micronutrients in HIV: A Bayesian Meta-Analysis EconPapers Economics at
your fingertips EconPapers Home About EconPapers Working Papers Journal Articles …
your fingertips EconPapers Home About EconPapers Working Papers Journal Articles …
Micronutrients in HIV: A Bayesian Meta-Analysis
GM Carter, D Indyk, M Johnson, M Andreae, K Suslov… - PLoS ONE, 2015 - go.gale.com
Background Approximately 28.5 million people living with HIV are eligible for treatment
(CD4< 500), but currently have no access to antiretroviral therapy. Reduced serum level of …
(CD4< 500), but currently have no access to antiretroviral therapy. Reduced serum level of …
[HTML][HTML] Micronutrients in HIV: A Bayesian Meta-Analysis
GM Carter, D Indyk, M Johnson, M Andreae, K Suslov… - PLoS ONE, 2015 - ncbi.nlm.nih.gov
Background Approximately 28.5 million people living with HIV are eligible for treatment
(CD4< 500), but currently have no access to antiretroviral therapy. Reduced serum level of …
(CD4< 500), but currently have no access to antiretroviral therapy. Reduced serum level of …
[PDF][PDF] Micronutrients in HIV: A Bayesian Meta-Analysis
GM Carter, D Indyk, M Johnson, M Andreae, K Suslov… - PLoS ONE, 2015 - academia.edu
Background Approximately 28.5 million people living with HIV are eligible for treatment
(CD4< 500), but currently have no access to antiretroviral therapy. Reduced serum level of …
(CD4< 500), but currently have no access to antiretroviral therapy. Reduced serum level of …
Micronutrients in HIV: a Bayesian meta-analysis
GM Carter, D Indyk, M Johnson, M Andreae, K Suslov… - PLoS ONE, 2015 - hero.epa.gov
BACKGROUND: Approximately 28.5 million people living with HIV are eligible for treatment
(CD4< 500), but currently have no access to antiretroviral therapy. Reduced serum level of …
(CD4< 500), but currently have no access to antiretroviral therapy. Reduced serum level of …